Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

NCT00370227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL: 10 valent pneumococcal conjugate (vaccine)

Sponsor

GlaxoSmithKline